Parvinder Thiara Biography and Net Worth

Director of Zura Bio

Parvinder Thiara has served as a Director of Zura since January 2026. He previously served as a member of the Board from June 2022 to May 2025.

Mr. Thiara founded Athanor Capital in 2017, a New York–based hedge fund manager, and currently serves as its Chief Investment Officer. He also served as a member of the board of directors of Tourmaline Bio, Inc. from September 2022 through the company’s acquisition by Novartis, which closed in October 2025. Previously, Mr. Thiara held various roles at D.E. Shaw & Co., including most recently as a Senior Vice President.

Mr. Thiara earned a Bachelor of Arts degree in Chemistry from Harvard College and a Master of Science degree in Theoretical Chemistry from the University of Oxford, where he was a Rhodes Scholar.

What is Parvinder Thiara's net worth?: The estimated net worth of Parvinder Thiara is at least $506.55 thousand as of November 17th, 2023. Thiara owns 83,782 shares of Zura Bio stock worth more than $506,546 as of April 1st. This net worth evaluation does not reflect any other assets that Thiara may own. Learn More about Parvinder Thiara's net worth.
How do I contact Parvinder Thiara?: The corporate mailing address for Thiara and other Zura Bio executives is C/O Maples Corporate Services Limited, Po Box 309 Ugland House, Grand Cayman KY1-11. Zura Bio can also be reached via phone at 858-247-0520 and via email at [email protected]. Learn More on Parvinder Thiara's contact information.
Has Parvinder Thiara been buying or selling shares of Zura Bio?: Parvinder Thiara has not been actively trading shares of Zura Bio over the course of the past ninety days. Most recently, Parvinder Thiara sold 1,001,633 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $2.73, for a transaction totalling $2,734,458.09. Learn More on Parvinder Thiara's trading history.
Who are Zura Bio's active insiders?: Zura Bio's insider roster includes Amit Munshi (Director), Kiran Nistala (EVP), and Parvinder Thiara (Director). Learn More on Zura Bio's active insiders.
Are insiders buying or selling shares of Zura Bio?: During the last year, Zura Bio insiders bought shares 1 times. They purchased a total of 2,000,000 shares worth more than $12,500,000.00. The most recent insider tranaction occured on February, 26th when Major Shareholder Ai Biotechnology Llc bought 2,000,000 shares worth more than $12,500,000.00. Insiders at Zura Bio own 22.1% of the company. Learn More about insider trades at Zura Bio.
Information on this page was last updated on 2/26/2026.

Parvinder Thiara Insider Trading History at Zura Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/25/2024	Sell	1,001,633	$2.73	$2,734,458.09

Parvinder Thiara Buying and Selling Activity at Zura Bio

Zura Bio Company Overview

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Today's Range

Now: $6.03

$5.93

$6.45

50 Day Range

MA: $6.27

$5.38

$7.04

2 Week Range

Now: $6.03

$0.97

$7.44

Volume

533,694 shs

Average Volume

669,076 shs

Market Capitalization

$572.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.18